MarketPeel
Insider Trading Intelligence
Pricing
…
HV

Hannah Valantine

BBIO
DIRECTOR · BRIDGEBIO PHARMA, INC. · CIK 0001855608
FILING MIX · LIFETIME62%/38%
BUYS
46
SELLS
28
TOTAL VALUE
$9.40M
COMPANIES
3
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
269,437
AVG SELL PX
$50.16
TRADE KIND
SHOWING 74 / 74
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
20 backtested trades · 8 horizons · 18 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Hannah Valantine, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d20+85.00%+2.23%-0.01%+2.25%+0.30%—
14d20+35.00%+1.56%+0.05%+1.51%+0.27%—
30d20+20.00%-7.84%-1.57%-6.27%-1.51%—
60d20+25.00%-11.27%+1.43%-12.71%-9.22%—
90d20+25.00%-5.24%+4.38%-10.41%-18.08%—
180d20(3 pending)+29.41%+9.68%+3.98%+5.71%-12.55%—
1y20(4 pending)+25.00%+6.67%+10.07%-3.41%-28.33%—
2y20(11 pending)+55.56%+156.87%+22.29%+134.59%+181.79%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BBIO · 9,259 shares · as of Jun 23, 2026
026,23052,46178,691104,92120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 46 buys / 28 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,196$68.57$150.6K9,259Jun 23, 2026Jun 24, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
2,808——5,617Jun 22, 2026Jun 24, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
2,808$41.73$117.2K14,263Jun 22, 2026Jun 24, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
3,990——11,455Jun 22, 2026Jun 24, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,808$68.00$190.9K11,455Jun 22, 2026Jun 24, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
5,277——5,277Jun 22, 2026Jun 24, 2026 ↗View →
CDNA
CAREDX, INC.
SALE10b5-1
10b5-1 plan
12,103$23.11$279.7K36,686Jun 15, 2026Jun 16, 2026 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
9,795——48,789Jun 12, 2026Jun 16, 2026 ↗View →
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PURCHASEGRANT
Stock grant
223,492——223,492Jun 3, 2026Jun 4, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,671$72.00$624.3K7,465Mar 10, 2026Mar 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
8,671——17,343Mar 10, 2026Mar 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
8,671$27.36$237.2K16,136Mar 10, 2026Mar 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
10,900$67.84$739.5K7,465Feb 27, 2026Mar 3, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
14,584$67.08$978.3K18,365Feb 27, 2026Mar 3, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
25,484——0Feb 27, 2026Mar 3, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
25,484$48.45$1.23M32,949Feb 27, 2026Mar 3, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
25,484——25,484Nov 12, 2025Nov 14, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
25,484$48.45$1.23M32,949Nov 12, 2025Nov 14, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
25,484$66.07$1.68M7,465Nov 12, 2025Nov 14, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
876$44.11$38.6K9,007Jun 26, 2025Jun 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
1,891$44.03$83.3K398Jun 26, 2025Jun 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
398$44.13$17.6K2,289Jun 26, 2025Jun 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
1,542$44.01$67.9K7,465Jun 26, 2025Jun 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
8,425——8,425Jun 20, 2025Jun 24, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
6,589——8,353Jun 20, 2025Jun 24, 2025 ↗View →
CDNA
CAREDX, INC.
SALE10b5-1
10b5-1 plan
10,570$19.16$202.6K38,994Jun 18, 2025Jun 23, 2025 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
12,103——49,564Jun 13, 2025Jun 17, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
4,292$40.00$171.7K1,764Jun 10, 2025Jun 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
4,292——34,334Jun 10, 2025Jun 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
4,292$16.75$71.9K6,056Jun 10, 2025Jun 11, 2025 ↗View →
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PURCHASEGRANT
Stock grant
65,000——65,000Jun 4, 2025Jun 6, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,875$32.58$419.5K1,764Mar 6, 2025Mar 7, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
12,875——38,626Mar 6, 2025Mar 7, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
12,875$16.75$215.7K14,639Mar 6, 2025Mar 7, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
26,014——26,014Jun 21, 2024Jun 25, 2024 ↗View →
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PURCHASEGRANT
Stock grant
32,179——32,179Jun 18, 2024Jun 20, 2024 ↗View →
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PURCHASEGRANT
Stock grant
22,821——22,821Jun 18, 2024Jun 20, 2024 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
10,570——37,461Jun 14, 2024Jun 18, 2024 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
16,048——16,048Jun 14, 2024Jun 18, 2024 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
16,048——16,048Jun 14, 2024Jun 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
2,915$8.45$24.6K4,679Feb 15, 2024Feb 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
2,915——93,261Feb 15, 2024Feb 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,915$37.75$110.0K1,764Feb 15, 2024Feb 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
2,915——96,176Jan 16, 2024Jan 18, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
2,915$8.45$24.6K4,679Jan 16, 2024Jan 18, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,915$37.97$110.7K1,764Jan 16, 2024Jan 18, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
2,915$8.45$24.6K4,679Dec 15, 2023Dec 19, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,915$36.12$105.3K1,764Dec 15, 2023Dec 19, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
2,915——99,091Dec 15, 2023Dec 19, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,915$30.00$87.5K1,764Nov 15, 2023Nov 17, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
2,915——102,006Nov 15, 2023Nov 17, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
2,915$8.45$24.6K4,679Nov 15, 2023Nov 17, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
51,501——51,501Jun 21, 2023Jun 23, 2023 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
18,844——26,891Jun 16, 2023Jun 21, 2023 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
29,136——29,136Jun 16, 2023Jun 21, 2023 ↗View →
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PURCHASEGRANT
Stock grant
25,775——25,775May 24, 2023May 26, 2023 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
676——8,047Jan 6, 2023Jan 9, 2023 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
422——7,371Oct 4, 2022Oct 4, 2022 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
325——6,949Jul 1, 2022Jul 6, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
104,921——104,921Jun 22, 2022Jun 24, 2022 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
4,863——6,624Jun 16, 2022Jun 21, 2022 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
7,606——7,606Jun 16, 2022Jun 21, 2022 ↗View →
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PURCHASEGRANT
Stock grant
63,015——63,015May 25, 2022May 27, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
1,752$14.24$24.9K3,294Dec 29, 2021Jun 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
1,764$14.23$25.1K1,764Dec 29, 2021Jan 3, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
1,542$12.68$19.6K1,542Dec 28, 2021Jun 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
796$13.16$10.5K2,687Dec 28, 2021Jun 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
1,891$13.18$24.9K1,891Dec 28, 2021Feb 13, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
1,542$12.68$19.6K3,433Dec 28, 2021Feb 13, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
50,968——50,968Oct 25, 2021Oct 26, 2021 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
131——1,761Oct 1, 2021Oct 4, 2021 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
1,630——1,630Jul 1, 2021Jul 2, 2021 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
1,630——1,630Jul 1, 2021Jul 2, 2021 ↗View →
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PURCHASEGRANT
Stock grant
28,992——28,992Jun 16, 2021Jun 21, 2021 ↗View →
Other insiders · BBIO
Loading peer insiders…
About this filer
CIK 0001855608
ROLE
Director
PRIMARY
BBIO
COMPANIES
3
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001855608DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback